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Received February 9, 2011; accepted June 9, 2011AbstractBackground: We investigated the differences in serum biochemistry levels between breast-fed and formula-fed infants. We provide reference
values of serum biochemistry levels for 4-week-old (w/o) and 8 w/o infants for future clinical applications.
Methods: Sixty healthy infants were enrolled in this study (30 infants were included in the breast-fed and formula-fed groups, respectively).
During hospital visits at 4 and 8 w/o, several parameters, including body weight, body length, and head circumference were recorded. Blood was
drawn to measure 14 serum biochemistry markers.
Results: There were no significant differences between the two groups in terms of growth or anthropometric measurements. Serum cholesterol,
triglyceride (TG), alanine aminotransferase (ALT), aspartataminotransferase (AST), gamma glutamyl transferase (GGT), total bilirubin (T-bil)
and direct bilirubin (D-bil) levels were significantly higher in the breast-fed group compared with those measured in the formula-fed group at
both 4 and 8 w/o. Serum blood urea nitrogen (BUN) and inorganic phosphate (IP) levels were significantly lower in the breast-fed group
compared with the formula-fed group at 4 and 8 w/o. In the formula-fed group, serum total protein (TP), albumin, cholesterol, uric acid (UA),
ALT, and AST levels were significantly higher in 8 w/o infants compared with 4 w/o infants; in addition, serum GGT, T-bil, D-bil, IP, and iron
(Fe) levels were significantly lower in 8 w/o infants compared with 4 w/o infants. In the breast-fed group, serum TP, albumin, and UA levels
were significantly higher in 8 w/o infants compared with 4 w/o infants; in addition, serum BUN, GGT, T-bil, D-bil, IP, and Fe levels were
significantly lower in 8 w/o infants compared with 4 w/o infants.
Conclusion: Different sources of nutrition may result in different metabolic responses; these differences are reflected by different serum
biochemistries. The reference values for serum biochemistry levels also differ according to the infant’s postnatal age.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Nutritionally, human breast milk is considered the best food
for infants under normal circumstances. However, there has been
a significant decline in the incidence and duration of breast-
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doi:10.1016/j.jcma.2011.09.007adjustments have beenmade to render formula as close to human
milk as possible, there are still differences in the composition of
humanmilk and various infant formulas.1Although some studies
have measured the reference values of various biochemical
constituents found in the sera of healthy infants,2,3 little is known
about the influence of different diets on the concentrations of
biochemical analytes in infants. Therefore, the present studywas
designed to investigate the differences in the serum biochemistry
levels of breast-fed and formula-fed infants and establish refer-
ence values for 4-week-old (w/o) and 8 w/o infants that can be
used in clinical applications.hinese Medical Association. All rights reserved.
512 T.-C. Wu et al. / Journal of the Chinese Medical Association 74 (2011) 511e5152. Methods2.1. Study populationThis 8-week metabolic study was conducted on apparently
healthy, full-term infants who were being fed either human
breast milk or formula. Infants were eligible for enrollment in
this study if they were delivered at full-term with a gestational
period of 38e42 weeks, had a 5-minute Apgar score of 8 or
higher, were in apparently in good health with no evidence of
cardiac, respiratory, gastrointestinal, or other systemic
diseases, had no history of birth asphyxia or clinically
apparent blood group incompatibilities, and if the mother had
no history of diabetes, tuberculosis, or perinatal infection with
proven effects on the fetus. In addition, the parents were
required to breast feed or provide their infants with the study
formula as the sole source of nutrition for the duration of the
study, voluntarily provide written informed consent, and
adhere to the design of this study. The study was approved by
the Institutional Review Board of the Taipei Veterans General
Hospital, Taiwan.2.2. Study procedureThirty eligible infants (15 males and 15 females) of
mothers who chose to breast feed were assigned to the human
breast milk group. These infants were exclusively breast fed
until 8 weeks of age. No other foods except water were
allowed during the study period. Another 30 eligible infants
(15 males and 15 females) from mothers who chose not to
breast feed were assigned a standard cow milk-based formula
(Similac with Iron infant formula, Abbott Laboratories,
Illinois, USA) and assigned to the formula-diet group. Infants
who failed to complete the study were replaced by an infant of
the same sex.
Dietary intake was recorded for 3 days prior to study visits
that were conducted at 4 and 8 w/o. The mothers of the
formula-fed infants provided information on the amount of
formula and other liquids ingested by their babies. Blood
samples were obtained at 4 and 8 w/o. Milk was the sole
source of nutrition for all infants during the first 8 weeks of
this study.2.3. Anthropometric and laboratory measurementsDuring the hospital visits at 4 and 8 w/o, several parame-
ters, including body weight, body length, and head circum-
ference, were recorded. Venous blood samples (3 mL) were
drawn from each infant between the hours of 8:00 AM and
12:00 PM, approximately 2e3 hours after feeding. Blood was
collected in order to determine several biochemical parame-
ters, including total protein (TP), albumin, cholesterol,
triglyceride (TG), blood urea nitrogen (BUN), uric acid (UA),
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), Gamma-glutamyltransferase (GGT), total bilirubin
(T-bil), direct bilirubin (D-bil), total calcium (Ca), inorganic
phosphate (IP), and iron (Fe) levels using a Hitachi 736-30system (Boehringer Mannheim Diagnostics [BMD], Indian-
apolis, IN, USA).2.4. Statistical analysesClinical and laboratory data were entered into a computer
data base for analysis using SPSS (SPSS Inc., Chicago, IL,
USA). Categorical data were analyzed using the Chi-square or
Fisher exact test. Continuous variables were compared using
the t test or the Wilcoxon sign rank test. For all tests, results
with p-values< 0.05 (two-tailed) were considered statistically
significant.
3. Results
There were no significant differences between the two
groups in terms of mean changes in body weight, length, or
head circumference that were measured between birth and 4 to
8 w/o, for either male or female infants.
As shown in Table 1, serum cholesterol, TG, ALT, AST,
GGT, T-bil, and D-bil levels were significantly higher in the
breast-fed group compared with the formula-fed group, both at
4 and 8 w/o. Serum BUN and IP levels were significantly
lower in the breast-fed group compared with the formula-fed
group at both 4 and 8 w/o.
In the formula group, Serum TP, albumin, cholesterol, UA,
ALT, and AST levels were significantly higher at 8 w/o
compared with 4 w/o infants; serum GGT, T-bil, D-bil, IP, and
Fe levels were significantly lower at 8 w/o compared with
4 w/o infants. In the breast-fed group, serum TP, albumin, and
UA levels were significantly higher in 8 w/o infants compared
with 4 w/o infants; serum BUN, GGT, T-bil, D-bil, IP, and Fe
levels were significantly lower in 8 w/o infants compared with
4 w/o infants.
Fig. 1 illustrates the differences in serum cholesterol, TG,
and total bilirubin levels between formula-fed and breast-fed
infants at different weeks of age. In 4 w/o infants, serum
cholesterol, TG and T-bilirubin levels were significantly higher
in the breast-fed infants compared with formula-fed infants by
35.91%, 30.27%, and 213.40%, respectively. When comparing
8 w/o infants, serum cholesterol, TG and T-bilirubin levels were
higher in breast-fed infants than formula-fed infants by 34.10%,
34.28%, and 182.05%, respectively.
4. Discussion
The concentration of urea in serum is inversely correlated
to the net utilization of proteins and reflects the balance
between intake, usage, and degradation of proteins and the
renal excretion of protein metabolites.4,5 Increased protein
intake induces an increase in amino acid oxidation and the
subsequent excretion of nitrogen, mainly as urea.4,6 The
concentration of nitrogen in the urine and serum increased
linearly with the amount of metabolizable protein that is fed to
lactating dairy cows, indicating the decreased efficiency of
nitrogen utilization.7 In this study, the reason for lower
concentrations of serum urea measured in 4 and 8 w/o infants
Table 1
Serum biochemistry levels measured in 60 healthy infants (30 infants in the breast-fed group; 30 infants in the formula-fed group) at different ages.
4 wk old 8 wk old
Formula-fed Breast-fed Formula-fed Breast-fed
TP 5.25 0.49 5.45 0.45b **5.43 0.31 **5.64 0.39
Albumin 3.77 0.28 3.85 0.29 **3.86 0.26 **4.04 0.27
Cholesterol 108.70 21.3 * 147.73 32.3 **111.48 20.2 * **149.50 26.8
TG 90.43 37.7 * 117.80 43.6 100.66 51.3 * 135.17 61.0
BUN 9.17 2.71 * 8.27 2.30 8.79 2.64* **6.00 2.11
UA 2.77 0.76 2.87 0.92 **3.40 1.03 **3.80 1.2
ALT 17.13 14.1 * 34.07 21.0 **24.93 18.2 * 40.00 22
AST 32.20 17.31 * 47.32 23.25 **38.66 14.9 * 54.24 19
GGT 46.13 27.5 * 70.62 42.24 **23.45 11.5 * **37.53 17.3
T-bil 0.97 0.45 * 3.04 2.19 **0.39 0.23 * **1.10 0.70
D-bil 0.14 0.15 * 0.28 0.27 **0.01 0.1 * **0.15 0.14
Ca 10.28 0.66 10.33 0.73 10.16 0.46 10.38 0.4
IP 7.27 1.09 * 6.53 0.77 **6.67 0.83 * **6.13 0.72
Fe 112.93 27.39 111.23 26.18 **74.00 24.2 **76.52 24.6
*p< 0.05 compared to breast-fed infants of the same age.
**p< 0.05 compared to 4 w/o infants for the same biochemical item.
ALT¼alanine aminotransferase; AST¼aspartataminotransferase; BUN¼ blood urea nitrogen; Ca¼ total calcium, D-bil¼ direct bilirubin; Fe¼ iron;
GGT¼ gamma glutamyl transferase; IP¼ inorganic phosphate; T-bil¼ total bilirubin; TG¼ triglyceride; TP¼ total protein; UA¼ uric acid.
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presumably more efficient use of proteins in the breast-fed
infants. Growth (e.g., weight, length, head circumference) and
albumin levels were similar between the two groups. Therefore,
these differences give evidence that the formulas that are now in
common use may provide a protein intake that is in excess of the
amount of protein required by infants. In addition, in contrast to
serum BUN levels at 4 w/o, the serum BUN levels measured in
8 w/o infants were lower in both the breast-fed and formula-fed
groups. This decrease in the serum BUN level could have
resulted from the maturation of the kidneys. This could also be
the reason why the inorganic phosphate (IP) value in infants was
lower at 8 w/o compared with 4 w/o.
In this study, serum ALT, AST and GGT levels were higher
in infants enrolled in the breast-fed group than infants enrolled
in the formula-fed group. This correlation was also reported in
a study performed in Denmark, which found that serum AST
levels are significantly higher in breast-fed infants because of
the induction of hepatocytes by factors found in human breast
milk.8 Human breast milk contains a variety of hormone andFig. 1. Differences in serum cholesterol, triglyceride, and total bilirubin levels
in breast-fed infants compared with formula-fed infants.hormone-like peptides, such as epidermal growth factor
(EGF), insulin-like growth factor-1 (IGF-1), and hepatocyte
growth factor (HGF), which are low or undetectable in infant
formula.9e11 Previous studies have shown that EGF is trans-
ported intact across the gastrointestinal mucosa during the
suckling period where it retains its influence on the develop-
ment of hepatic microcirculation and the phagocytic functions
of Kupffer cells in the postpartum liver.9,12e15 Recent
evidence also suggests that EGF receptor-dependent signaling
contributes not only to liver cell proliferation but also the
regulation of hepatic regeneration.16 Also, HGF is abundant in
human breast milk and is involved in the proliferation of
hepatocytes.17e19 Supported by this evidence, we believe that
the most likely explanation for the elevated AST, ALT, and
GGT values in the breast-fed infants is the stimulation of liver
metabolism through one or several growth factors that are
naturally found in human breast milk.
It is well established that breast-fed infants are at a higher
risk of developing hyperbilirubinemia. Although the patho-
genesis of hyperbilirubinemia is not well understood, the
inhibition of hepatic UDP-glucuronyltransferase, increased
enterohepatic recirculation of bilirubin, and low levels of
intestinal bacteria capable of converting bilirubin to non-
resorbable derivatives are possible causes.20 A recent study
suggested that neonatal hyperbilirubinemia is significantly
correlated with the concentration of EGF, which is more
abundant in breast milk.21 This disparity between serum bili-
rubin levels was also found in this study. The concentrations of
total and direct bilirubin were higher in breast-fed infants at 4
and 8 w/o than those that were fed formula. The mean serum
level, however, was well below the threshold for pathologic
jaundice (<15 mg/dL). The relatively elevated level of bili-
rubin in the breast-fed infants may also have long-term
favorable effects. Bilirubin has been recently recognized for
its cytoprotective and anti-oxidant properties. Reduced serum
bilirubin levels are associated with a higher prevalence of
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protective effects of serum bilirubin against malignancies.22,23
Cholesterol is an essential component of the brain,
accounting for 2e3% of its weight and 20e30% of its total
lipids.24 Higher concentrations of serum cholesterol were
measured in the breast-fed infants in this study, in accordance
with the results of previous studies.25e28 This difference has
been attributed to the greater cholesterol content, usually
between 10e20 mg cholesterol/dL, found in human milk,
whereas infant formulas in the US contain less than 10% of
this amount of cholesterol.28e30 Furthermore, several of the
long-chain (i.e., n-3) and polyunsaturated fatty acids (i.e., n-6)
present in human milk, including arachidonic acids, are absent
in formula. The lipid content of human milk could reflect the
needs of the brain during this active period of growth. Our
previous study showed that the levels of linoleic acid, alpha
linoleic acic, arachidonic acid, and docosahexaenoic acid in
Taiwanese infants are the highest among several countries that
were studied.31 Many studies have shown that adolescents and
adults who were breast-fed during infancy have lower serum
levels of cholesterol and LDL.32,33 The high intake of
cholesterol by breast-fed infants may downregulate hepatic
hydroxymethyl glutaryl coenzyme A reductase, thereby
resulting in the reduced endogenous synthesis of cholesterol in
later life.26 Whether or not breast feeding has a profound
impact on future cardiovascular events is still controversial.
Human breast milk contains a considerable amount of
nucleotides, the possible biological effects of which, such as the
enhancement of immune functions, increase in the available
iron, modification of intestinal microflora, changes in plasma
lipids, and promotion of gut growth and maturation, have been
reviewed. The nucleotide content of bovinemilk is less, but also
of a different composition.34,35 Human breast milk and fetal
mucosal enterocyte contain the complete sequence of enzymes
necessary to completely convert purine nucleotides to uric
acid.36 This is the possible reason why there were higher levels
of serum uric acid in breast-fed children at 4 and 8 w/o, though
this finding was not statistically significant.
In conclusion, different types of nutrition intake may result
in different metabolic responses, which are reflected by
different serum biochemistries. Not only does breast milk
provide the ideal nutritional content for newborns, but it also
contains a variety of substances that may actively influence the
growth and development of infants. The reference values for
serum biochemical levels also differ depending on the infant’s
age (e.g., from birth to 8 w/o).References
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